Forvis Mazars is a leading international audit, tax and advisory firm, aspiring to build the economic foundations of a fair and prosperous world.

Forvis Mazars is the brand name for the Forvis Mazars global network (Forvis Mazars Global Limited), a leading global professional services network with just two independent members: 

- Forvis Mazars Group SC (formerly Mazars Group SC), an internationally fully integrated partnership operating in over 100 countries and territories, and 

- Forvis Mazars, LLP (formerly FORVIS LLP) in the United States

Forvis Mazars provides comprehensive support to Life Sciences Companies across all global regions through a network of six strategically positioned hubs. These hubs serve as centralized platforms for our consulting and advisory teams, ensuring consistent delivery of integrated solutions and strategic guidance worldwide.

We are Merck KGaA, Darmstadt, Germany, a vibrant science and technology company.

Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create.

The passion of our curious minds makes a positive difference to millions of people’s lives every day.

In Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information.

Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live.

We are curious minds dedicated to human progress.

Oppenheimer is a global financial institution offering Wealth Management, Capital Markets, and Investment Banking solutions. We have been providing customized solutions centered on the goals of our clients since 1881 — using our extensive experience, resources, research, and knowledge to help advance society, improve our communities, and leave the world a better place

The Paris-Saclay Cancer Cluster (PSCC) is a European-scale oncology biocluster with global ambitions, created to accelerate the translation of cutting-edge cancer science into precision therapies, diagnostics and technologies.

As the first biocluster established under the French Government’s France 2030 investment plan, PSCC brings together more than 180 start-ups, biotech companies, pharmaceutical groups, investors, research organisations, hospitals and public institutions. Its role is to connect promising oncology innovators with the expertise, infrastructure, capital and industrial partners needed to de-risk development and accelerate growth.

PSCC offers start-ups access to a curated ecosystem of scientific and clinical expertise, mentoring, data resources, laboratory infrastructure, funding opportunities and strategic connections. Anchored at Campus Grand Parc, in greater Paris, PSCC provides a dedicated hub where entrepreneurs, researchers, clinicians, investors and industry partners can collaborate daily to transform scientific breakthroughs into clinical and industrial impact.

For 75 years, Baker McKenzie has helped clients navigate the complexities of an ever-changing world.

From the civil rights movement to the fall of the Berlin wall and the invention of the world wide web, we've witnessed fundamental shifts in business and society over the last eight decades. But as the original global law firm, we've been steadfast in solving our clients' problems — wherever they are in the world — by providing a unique blend of local expertise and global context.

Baker McKenzie's Healthcare & Life Sciences group is one of the largest of any international law firm, comprising more than 800 lawyers in more than 40 countries. The team, which includes professionals with scientific backgrounds, is recognized by clients and industry peers for the premium quality advice it provides across all aspects of legal issues that healthcare, life sciences, biotech and medical devices companies face, including: M&As, reorganizations; carve-outs; divestitures; collaborations; licensing and other commercial arrangements; tax; regulatory compliance; data and technology; intellectual property advertising and promotion; employment and compensation; ESG and sustainability; competition; supply chains; trade; product safety and liability; and litigation. No other law firm has as many healthcare industry specialists in as many countries as we do. In an ever-changing, highly regulated, multijurisdictional industry, this is a game changer. Our dedication to legal excellence is globally acknowledged, supported by our innovative solutions and an extensive global presence encompassing more than 70 offices across more than 40 countries.

Cancer Research Horizons is the innovation engine of Cancer Research UK – the world's largest charitable funder of cancer research.

With access to Cancer Research UK’s network of 4,000 exceptional scientists and funding of £400m of world-class academic research each year, Cancer Research Horizons is chaning the way we prevent, diagnose, and treat cancer. The Company offers the full spectrum of translational expertise, from drug discovery and clinical capabilities, translational funding and entrepreneurial training to licensing, industry collaboration and start- up creation expertise. It has played a role in the creation of over 95 start-ups, with its portfolio companies raising over £3bn in total capital.

Its dedicated Ventures team focuses on early-stage, high-risk companies, including one of the most challenging stages of start-up creation: attracting early-stage risk capital. The Ventures team manages the Cancer Research Horizons Seed Fund, launched in June 2022, to accelerate more breakthroughs to patient benefit.

Ropes & Gray is a preeminent global law firm, with more than 1500 legal professionals serving clients in key centers of business, technology and government.

An economic powerhouse situated on the border of three countries, Basel-Stadt offers a very dynamic business environment. A healthy ecosystem thrives on its diversity to enrich and pollinate each other. Existing blue-chip companies, international companies that settle here, leading research institutes and SME’s rub shoulders with vibrant startups, prolific incubators and multinationals which thrive in the area. Born in the nucleus of life sciences innovation, Basel-Stadt flourishes as an international hub of innovation, culture and business acumen.
 
Switzerland is considered the most innovative country in the world, according to a number of studies. Access to knowledge, highly qualified and international talent and a supportive government have turned Basel into the leading innovation hub of Switzerland. A future-oriented outlook with continuous innovation marks Basel as an international leader in life sciences, healthcare, ICT technology and circular economy.

With a population of 200,000, Basel may seem to be a small city, but its rich economic and cultural offerings put it firmly in the big league. Many international companies and well-known brands such as Novartis, Roche, Lonza, Moderna, BeiGgene, Bayer and Syngenta have their headquarters here, and the city has a thriving, multi-cultural, well-educated expat community coming from more than 160 different countries.

Ropes & Gray is a preeminent global law firm, with more than 1500 legal professionals serving clients in key centers of business, technology and government.